Endocrine therapy-induced alopecia seen in breast cancer

April 12, 2018

(HealthDay)—For patients with breast cancer, endocrine therapy-induced alopecia (EIA) has a pattern that is similar to androgenetic alopecia, according to a study published online April 11 in JAMA Dermatology.

Azael Freites-Martinez, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a to characterize EIA in 112 patients with , diagnosed with EIA from Jan. 1, 2009, to Dec. 31, 2016.

The researchers found that in 67 and 33 percent of patients, alopecia was attributed to aromatase inhibitors and tamoxifen, respectively. Ninety-two percent of patients had grade 1 severity, and the pattern was similar to . At baseline, the predominant trichoscopic feature was the presence of vellus hairs and intermediate- and thick-diameter terminal hair shafts. There was a negative impact on quality of life; according to the Hairdex score, there was a higher effect in the emotion domain. Eighty percent of the 46 patients assessed for response to minoxidil had moderate or significant improvement in alopecia after treatment.

"Endocrine therapies are associated with a pattern alopecia similar to androgenetic-type, consistent with the mechanism of action of causal agents," the authors write. "A significant negative impact on quality of life was reported by patients, despite mostly mild alopecia severity."

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Frontal fibrosing alopecia negatively linked to HRQOL

More information: Abstract/Full Text
Editorial (subscription or payment may be required)

Related Stories

Frontal fibrosing alopecia negatively linked to HRQOL

March 9, 2018
(HealthDay)—Frontal fibrosing alopecia (FFA) is negatively linked to health-related quality of life (HRQOL), according to a research letter published online March 7 in JAMA Dermatology.

Vitamin D deficiency linked to alopecia areata severity

July 13, 2017
(HealthDay)—For pediatric patients with alopecia areata (AA), vitamin D is negatively correlated with disease severity, number of patches, and disease duration, according to a study published online recently in the Journal ...

Zinc levels may predict worse outcomes with alopecia

July 10, 2015
(HealthDay)—Lower serum zinc levels are associated with worse outcomes in patients with alopecia areata, according to a study published online July 3 in the International Journal of Dermatology.

Dry eye disease often diagnosed in alopecia areata

October 30, 2015
(HealthDay)—Many patients with alopecia areata are diagnosed with dry eye disease (DED), and patients should be referred for an ophthalmic evaluation, according to a study published in the November issue of the International ...

Oxidative stress tied to early-onset androgenetic alopecia

December 27, 2016
(HealthDay)—Younger patients with early-onset androgenetic alopecia (AGA) have increased oxidative stress, according to a study published online Dec. 16 in the Journal of Cosmetic Dermatology.

Men perceived as younger, more attractive after hair transplant for baldness

August 25, 2016
Does how much hair a man has matter in how he is perceived? The answer is yes, according to a new article published online by JAMA Facial Plastic Surgery.

Recommended for you

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

October 22, 2018
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, ...

Revealing the molecular mystery of human liver cells

October 22, 2018
A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular ...

Targeting a hunger hormone to treat obesity

October 22, 2018
About 64 per cent of Canadian adults are overweight or obese, according to Health Canada. That's a problem, because obesity promotes the emergence of chronic diseases such as type 2 diabetes, heart disease and some cancers.

New tool gives deeper understanding of glioblastoma

October 22, 2018
Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to study genetic "switches" active in glioblastoma tumors that drive growth of the cancer. In a new paper in Nature ...

Pancreatic cancer genetic marker may predict outcomes with radiation therapy

October 22, 2018
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center—Jefferson Health and Lankenau Institute for Medical Research scientists find ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.